Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJohnson Matthey Regulatory News (JMAT)

Share Price Information for Johnson Matthey (JMAT)

Share Price is delayed by 15 minutes
Get Live Data
2,080.00    -62.00 (-2.89%)
Bid:
2,066.00
Ask:
2,070.00
Spread: 4.00 (0.194%)
Market Cap: £3.48b
JMAT Live PriceLast checked at - London Stock Exchange

Intraday Johnson Matthey Share Chart

Organisation Changes

20 Apr 2017 16:00

RNS Number : 9050C
Johnson Matthey PLC
20 April 2017
 

For release at 4.00 pm Thursday 20th April 2017

 

JM at 200 - Aligned for Growth

 

Johnson Matthey announces changes to its organisation

 

In 2017 Johnson Matthey celebrates its 200th year and in May we will launch a refreshed brand identity, "Inspiring science, enhancing life", to reflect our position as first and foremost a science led company which has a major positive impact on people's lives; making the world around us cleaner and healthier.

 

Johnson Matthey has made, and continues to make, significant progress in these areas but in order to perform in the current environment, we must increase our focus and build a more collaborative organisation. This will drive further synergies for customers and create value for shareholders. To achieve this, and to reinforce Johnson Matthey's brand identity, we will move to a group structure of four sectors aligned on the global priorities of cleaner air, the efficient use of natural resources and improved health:

· Clean Air

· Efficient Natural Resources

· Health

· New Markets

 

Clean Air is the new name for Emission Control Technologies Division. John Walker, Executive Director, will continue to lead this sector.

 

Efficient Natural Resources brings together Process Technologies Division and much of Precious Metal Products Division. There is an opportunity to deepen our presence in the chemicals, oil and gas, and industrial markets by enabling our customers to increase their efficient use of resources; making more out of less. Jane Toogood, currently Division Director of Precious Metal Products, will lead this sector.

 

Health will comprise much of our Fine Chemicals Division. Johnson Matthey is well positioned to build in this space through focusing on niche areas where we can differentiate using our expertise in complex chemistry. We will bring in a new leader from outside Johnson Matthey to head this sector. In the interim, Robert MacLeod, Chief Executive, will oversee this sector.

 

New Markets is the new name for our New Businesses Division. In addition to the current portfolio of businesses, it will incorporate the Medical Components business previously included in Precious Metal Products' Noble Metals business, and Fine Chemicals' Catalysis and Chiral Technologies business. Alan Nelson, currently Chief Technology Officer and Division Director of New Businesses, will lead this sector.

 

These changes are with immediate effect.

 

 

Enquiries:

Investor Relations

Simon McGough

Sarah Armstrong

 

Head of Investor Relations

Head of Investor Relations

 

020 7269 8235

020 7269 8426

Katharine Burrow

 

Media

Sally Jones

David Allchurch

Investor Relations Analyst

 

 

Director of Corporate Relations

Tulchan Communications

020 7269 8444

 

 

020 7269 8407

020 7353 4200

www.matthey.com

 

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCEALLEALSXEFF
Date   Source Headline
15th Aug 201811:22 amRNSDirector/PDMR Shareholding
15th Aug 201811:11 amRNSDirector/PDMR Shareholding
9th Aug 20182:53 pmRNSDirector/PDMR Shareholding
9th Aug 20182:20 pmRNSDirector/PDMR Shareholding
9th Aug 20182:17 pmRNSDirector/PDMR Shareholding
8th Aug 20184:09 pmRNSDirector/PDMR Shareholding
3rd Aug 20182:01 pmRNSDirector/PDMR Shareholding
3rd Aug 20182:00 pmRNSDirector/PDMR Shareholding
2nd Aug 20184:11 pmRNSDirector/PDMR Shareholding
2nd Aug 20184:10 pmRNSDirector/PDMR Shareholding
2nd Aug 20184:06 pmRNSDirector/PDMR Shareholding
26th Jul 20182:58 pmRNSResult of AGM
26th Jul 20187:00 amRNSAGM trading update
19th Jul 20185:34 pmRNSHolding(s) in Company
19th Jul 20184:24 pmRNSDirector/PDMR Shareholding
12th Jul 20182:20 pmRNSHolding(s) in Company
25th Jun 20184:04 pmRNSHolding(s) in Company
21st Jun 201812:12 pmRNSDirector/PDMR Shareholding
20th Jun 20187:00 amRNSAnnual Financial Report
31st May 20187:00 amRNSPreliminary results for year ended 31st March 2018
17th May 20183:29 pmRNSDirector/PDMR Shareholding
19th Apr 20184:41 pmRNSDirector/PDMR Shareholding
16th Apr 20187:25 amRNSDirectorate Change
23rd Mar 20182:18 pmRNSDirector/PDMR Shareholding
22nd Mar 20182:48 pmRNSDirector/PDMR Shareholding
5th Mar 20187:00 amRNSResult of the External Audit Tender
2nd Mar 20187:00 amRNSAppointment of Sector Chief Executive, Health
22nd Feb 201812:16 pmRNSDirector/PDMR Shareholding
9th Feb 20189:39 amRNSDirector/PDMR Shareholding
8th Feb 20184:48 pmRNSDirector/PDMR Shareholding
8th Feb 20184:43 pmRNSDirector/PDMR Shareholding
8th Feb 20184:41 pmRNSDirector/PDMR Shareholding
7th Feb 20187:00 amRNSJohnson Matthey business update
31st Jan 20181:00 pmRNSJM and Cummins Expand Efforts in Electrification
18th Jan 20182:12 pmRNSDirector/PDMR Shareholding
21st Dec 201710:17 amRNSDirector/PDMR Shareholding
22nd Nov 201712:20 pmRNSDirector/PDMR Shareholding
21st Nov 20177:00 amRNSHalf year results
16th Nov 201712:37 pmRNSDirector/PDMR Shareholding
20th Oct 20179:07 amRNSColin Matthews - New Directorship
19th Oct 20174:29 pmRNSDirector/PDMR Shareholding
22nd Sep 20172:12 pmRNSDirector/PDMR Shareholding
21st Sep 20177:00 amRNSCapital Markets Day Statement
18th Aug 201711:38 amRNSDirector/PDMR Shareholding
18th Aug 201711:34 amRNSDirector/PDMR Shareholding
18th Aug 201711:26 amRNSDirector/PDMR Shareholding
17th Aug 20175:00 pmRNSHolding(s) in Company
17th Aug 20173:33 pmRNSDirector/PDMR Shareholding
4th Aug 20172:14 pmRNSDirector/PDMR Shareholding
3rd Aug 20173:59 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.